Finally moving forward in adult ALL

Blood

Volumn 125, Issue 16, 2015, Pages 2453-2454

  Litzow, Mark R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; HUMAN; INDUCTION CHEMOTHERAPY; INTENSIVE CARE; MINIMAL RESIDUAL DISEASE; NOTE; OUTCOME ASSESSMENT; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; TREATMENT RESPONSE; CLINICAL TRIAL (TOPIC); FEMALE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROCEDURES; STEM CELL TRANSPLANTATION;

CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; STEM CELL TRANSPLANTATION;

EID: 84927729448     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-02-623793     Document Type: Note

References (8)

1. Dhédin N, Huynh A, Maury S, et al. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood. 2015;125(16):2486-2496.
2. Stock W, La M, Sanford B, et al Children's Cancer Group; Cancer and Leukemia Group B studies. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008;112(5):1646-1654.
3. Huguet F, Leguay T, Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009;27(6):911-918.
4. Stock W, Luger SM, Advani AS, et al. Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of U.S. intergroup trial C10403 [abstract]. Blood. 2014;124(21). Abstract 796.
5. Trinquand A, Tanguy-Schmidt A, Ben Abdelali R, et al. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol. 2013;31(34):4333-4342.
6. Beldjord K, Chevret S, Asnafi V, et al Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL). Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014;123(24):3739-3749.
7. Seftel MD, Neuberg D, Zhang M-J, et al. Superiority of pediatric chemotherapy over allogeneic hematopoietic cell transplantation for Philadelphia chromosome negative adult ALL in first complete remission: a combined analysis of Dana-Farber ALL consortium and CIBMTR cohorts [abstract]. Blood. 2014;124(21). Abstract 319.
8. Parikh SA, Litzow MR. Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development. Future Oncol. 2014;10(14):2201-2212.